CLEC5A
C-type lectin domain family 5 member A
Also known as: CLC5A_HUMAN, CLECSF5, MDL-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NY25
- Gene
- CLEC5A
- Ensembl
- ENSG00000258227
- Chromosome
- 7
- Canonical length
- 188 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. The encoded type II transmembrane protein interacts with dnax-activation protein 12 and may play a role in cell activation. Alternative splice variants have been described but their full-length sequence has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
188 residues, UniProt reviewed canonical sequence.
>Q9NY25|CLEC5A
1 MNWHMIISGL IVVVLKVVGM TLFLLYFPQI FNKSNDGFTT TRSYGTVSQI FGSSSPSPNG
61 FITTRSYGTV CPKDWEFYQA RCFFLSTSES SWNESRDFCK GKGSTLAIVN TPEKLKFLQD
121 ITDAEKYFIG LIYHREEKRW RWINNSVFNG NVTNQNQNFN CATIGLTKTF DAASCDISYR
181 RICEKNAKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLEC5A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 39 nTPM
- appendix: 6.9 nTPM
- lung: 3.8 nTPM
- choroid plexus: 3.7 nTPM
- blood vessel: 2.7 nTPM
- skin: 2.5 nTPM
Single-cell type
- neutrophil progenitors: 67 nCPM
- macrophages: 42 nCPM
- cdc: 35 nCPM
- monocytes: 24 nCPM
- neutrophils: 23 nCPM
- epicardial cells: 11 nCPM
Immune cell
- classical monocyte: 9.1 nTPM
- total PBMC: 1.8 nTPM
- intermediate monocyte: 1.1 nTPM
- neutrophil: 1.1 nTPM
- myeloid DC: 0.4 nTPM
- plasmacytoid DC: 0.2 nTPM
Brain region
- thalamus: 9.7 nTPM
- hypothalamus: 6.7 nTPM
- midbrain: 5.6 nTPM
- cerebral cortex: 4.9 nTPM
- white matter: 4 nTPM
- medulla oblongata: 3.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 0.24
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular defense response
- innate immune response
- myeloid cell differentiation
- negative regulation of apoptotic process
- negative regulation of myeloid cell apoptotic process
- osteoblast development
- positive regulation of cytokine production
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C-type lectin-like
- C-type lectin-like/link domain superfamily
- C-type lectin fold
- Natural killer cell receptor-like, C-type lectin-like domain
- Lectin C-type domain
- C-type lectin domain-containing protein 5A
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLEC5A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLEC5A as an antibody target. Whether an autoantibody or antibody against CLEC5A could matter depends on whether native CLEC5A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLEC5A is annotated at the cell surface, where native CLEC5A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CLEC5A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...